Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://www.nature.com/articles/6604216.pdf
Reference42 articles.
1. Alam SM, Fujimoto J, Jahan I, Sato E, Tamaya T (2007) Overexpression of ephrinB2 and EphB4 in tumor advancement of uterine endometrial cancers. Ann Oncol 18 (3): 485–490
2. Brambilla R, Schnapp A, Casagranda F, Labrador JP, Bergemann AD, Flanagan JG, Pasquale EB, Klein R (1995) Membrane-bound LERK2 ligand can signal through three different Eph related receptor tyrosine kinases. EMBO J 14: 3116–3126
3. Brantley DM, Cheng N, Thompson EJ, Lin Q, Brekken RA, Thorpe PE, Muraoka RS, Cerretti DP, Pozzi A, Jackson D, Lin C, Chen J (2002) Soluble EphA receptors inhibit tumor angiogenesis and progression in vivo. Oncogene 21: 7011–7026
4. Castellano G, Reid JF, Alberti P, Carcangiu ML, Tomassetti A, Canevari S (2006) New potential ligand–receptor signaling loops in ovarian cancer identified in multiple gene expression studies. Cancer Res 66 (22): 10709–10719
5. Castellvi J, Garcia A, Torre J, Hernandez J, Gil A, Xercavins J, Cajal SR (2006) Ephrin B expression in epithelial ovarian neoplasms correlate with tumor differentiation and angiogenesis. Hum Pathol 37: 883–889
Cited by 50 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Development of an Anti-EphB4 Monoclonal Antibody for Multiple Applications Against Breast Cancers;Monoclonal Antibodies in Immunodiagnosis and Immunotherapy;2023-10-01
2. Lymphatic vasculature in ovarian cancer;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-09
3. Anti-angiogenic therapy in ovarian cancer: Current understandings and prospects of precision medicine;Frontiers in Pharmacology;2023-03-07
4. The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management;International Journal of Molecular Sciences;2022-03-17
5. The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread;International Journal of Molecular Sciences;2021-08-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3